These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37792954)

  • 1. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
    Freyn AW; Atyeo C; Earl PL; Americo JL; Chuang GY; Natarajan H; Frey TR; Gall JG; Moliva JI; Hunegnaw R; Asthagiri Arunkumar G; Ogega CO; Nasir A; Santos G; Levin RH; Meni A; Jorquera PA; Bennett H; Johnson JA; Durney MA; Stewart-Jones G; Hooper JW; Colpitts TM; Alter G; Sullivan NJ; Carfi A; Moss B
    Sci Transl Med; 2023 Oct; 15(716):eadg3540. PubMed ID: 37792954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses.
    Radaelli A; Zanotto C; Brambilla C; Adami T; Paolini F; Venuti A; Manuka A; Mehmeti I; De Giuli Morghen C
    Virol J; 2024 Nov; 21(1):282. PubMed ID: 39511612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation?
    Mariotti S; Venturi G; Chiantore MV; Teloni R; De Santis R; Amendola A; Fortuna C; Marsili G; Grilli G; Lia MS; Kiros ST; Lagi F; Bartoloni A; Iacobino A; Cresta R; Lastilla M; Biselli R; Di Bonito P; Lista F; Nisini R
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
    Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q
    BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice.
    Zhu J; Wang Z; Li Y; Zhang Z; Ren S; Wang J; Xie S; Liao Z; Song B; Wu W; Yan F; Peng C
    J Virol; 2024 Jul; 98(7):e0052124. PubMed ID: 38874361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets.
    Waqas M; Aziz S; Liò P; Khan Y; Ali A; Iqbal A; Khan F; Almajhdi FN
    Front Immunol; 2023; 14():1091941. PubMed ID: 36776835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
    Hishiki T; Morita T; Akazawa D; Ohashi H; Park ES; Kataoka M; Mifune J; Shionoya K; Tsuchimoto K; Ojima S; Azam AH; Nakajima S; Kawahara M; Yoshikawa T; Shimojima M; Kiga K; Maeda K; Suzuki T; Ebihara H; Takahashi Y; Watashi K
    Microbiol Spectr; 2023 Aug; 11(4):e0056623. PubMed ID: 37409948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus.
    Kong T; Du P; Ma R; Wang H; Ma X; Lu J; Gao Z; Qi H; Li R; Zhang H; Xia F; Liu Y; Wang R; Duan K; Wang Z; Wang Q; Gao GF
    EBioMedicine; 2024 Nov; 109():105392. PubMed ID: 39423738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.
    Otter AD; Jones S; Hicks B; Bailey D; Callaby H; Houlihan C; Rampling T; Gordon NC; Selman H; Satheshkumar PS; Townsend M; Mehta R; Pond M; Jones R; Wright D; Oeser C; Tonge S; Linley E; Hemingway G; Coleman T; Millward S; Lloyd A; Damon I; Brooks T; Vipond R; Rowe C; Hallis B
    Nat Commun; 2023 Sep; 14(1):5948. PubMed ID: 37741831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineating multi-epitopes vaccine designing from membrane protein CL5 against all monkeypox strains: a pangenome reverse vaccinology approach.
    Alsaiari AA; Hakami MA; Alotaibi BS; Alkhalil SS; Alkhorayef N; Khan K; Jalal K
    J Biomol Struct Dyn; 2024 Oct; 42(16):8385-8406. PubMed ID: 37599459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unique immune evasion mechanisms of the mpox virus and their implication for developing new vaccines and immunotherapies.
    Fang D; Liu Y; Dou D; Su B
    Virol Sin; 2024 Oct; 39(5):709-718. PubMed ID: 39181538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
    Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
    J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of exanthematous viruses during the 2022 Mpox outbreak in Minas Gerais, Brazil.
    Adelino TÉR; Santos SC; Lima MT; da Costa AVB; Guimarães NR; Tomé LMR; Silva MVF; Pereira AM; Luiz KCM; Lamounier LO; Gomes Júnior AC; Ribeiro AA; Alvarez P; Arruda MB; Kroon EG; Guerra-Duarte C; Iani FCdM
    J Clin Microbiol; 2024 Jun; 62(6):e0010324. PubMed ID: 38785446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
    Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N
    Hum Vaccin Immunother; 2024 Dec; 20(1):2408863. PubMed ID: 39422261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International external quality assessment study for detection of monkeypox virus by PCR supporting laboratory preparedness during the 2022-2023 mpox outbreak and beyond.
    Ehmann R; Donoso Mantke O; McCulloch E; Yousef A; Ricketts A; Staines H; Bugert JJ; Wölfel R; Niesters HGM
    J Clin Virol; 2024 Dec; 175():105741. PubMed ID: 39488925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice.
    Gao F; He C; Liu M; Yuan P; Tian S; Zheng M; Zhang L; Zhou X; Xu F; Luo J; Li X
    Virol J; 2023 Jun; 20(1):126. PubMed ID: 37337226
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.